OBJECTIVE: To analyze the methylome of normal and osteoarthritic (OA) knee articular cartilage and to determine the role of DNA methylation in the regulation of gene expression in vitro. METHODS: DNA was isolated from human normal (n = 11) and OA (n = 12) knee articular cartilage and analyzed using the Infinium HumanMethylation450 BeadChip array. To integrate methylation and transcription, RNA sequencing was performed on normal and OA cartilage and validated by quantitative polymerase chain reaction. Functional validation was performed in the human TC28 cell line and primary chondrocytes that were treated with the DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-dC). RESULTS: DNA methylation profiling revealed 929 differentially methylated sites between normal and OA cartilage, comprising a total of 500 individual genes. Among these, 45 transcription factors that harbored differentially methylated sites were identified. Integrative analysis and subsequent validation showed a subset of 6 transcription factors that were significantly hypermethylated and down-regulated in OA cartilage (ATOH8, MAFF, NCOR2, TBX4, ZBTB16, and ZHX2). Upon 5-aza-dC treatment, TC28 cells showed a significant increase in gene expression for all 6 transcription factors. In primary chondrocytes, ATOH8 and TBX4 were increased after 5-aza-dC treatment. CONCLUSION: Our findings reveal that normal and OA knee articular cartilage have significantly different methylomes. The identification of a subset of epigenetically regulated transcription factors with reduced expression in OA may represent an important mechanism to explain changes in the chondrocyte transcriptome and function during OA pathogenesis.
OBJECTIVE: To analyze the methylome of normal and osteoarthritic (OA) knee articular cartilage and to determine the role of DNA methylation in the regulation of gene expression in vitro. METHODS: DNA was isolated from human normal (n = 11) and OA (n = 12) knee articular cartilage and analyzed using the Infinium HumanMethylation450 BeadChip array. To integrate methylation and transcription, RNA sequencing was performed on normal and OA cartilage and validated by quantitative polymerase chain reaction. Functional validation was performed in the humanTC28 cell line and primary chondrocytes that were treated with the DNA methylation inhibitor 5-aza-2'-deoxycytidine (5-aza-dC). RESULTS: DNA methylation profiling revealed 929 differentially methylated sites between normal and OA cartilage, comprising a total of 500 individual genes. Among these, 45 transcription factors that harbored differentially methylated sites were identified. Integrative analysis and subsequent validation showed a subset of 6 transcription factors that were significantly hypermethylated and down-regulated in OA cartilage (ATOH8, MAFF, NCOR2, TBX4, ZBTB16, and ZHX2). Upon 5-aza-dC treatment, TC28 cells showed a significant increase in gene expression for all 6 transcription factors. In primary chondrocytes, ATOH8 and TBX4 were increased after 5-aza-dC treatment. CONCLUSION: Our findings reveal that normal and OA knee articular cartilage have significantly different methylomes. The identification of a subset of epigenetically regulated transcription factors with reduced expression in OA may represent an important mechanism to explain changes in the chondrocyte transcriptome and function during OA pathogenesis.
Authors: Michael B Stadler; Rabih Murr; Lukas Burger; Robert Ivanek; Florian Lienert; Anne Schöler; Erik van Nimwegen; Christiane Wirbelauer; Edward J Oakeley; Dimos Gaidatzis; Vijay K Tiwari; Dirk Schübeler Journal: Nature Date: 2011-12-14 Impact factor: 49.962
Authors: María C de Andrés; Kei Imagawa; Ko Hashimoto; Antonio Gonzalez; Helmtrud I Roach; Mary B Goldring; Richard O C Oreffo Journal: Arthritis Rheum Date: 2013-03
Authors: M B Goldring; J R Birkhead; L F Suen; R Yamin; S Mizuno; J Glowacki; J L Arbiser; J F Apperley Journal: J Clin Invest Date: 1994-12 Impact factor: 14.808
Authors: Ana M Valdes; Deborah J Hart; Karen A Jones; Gabriela Surdulescu; Peter Swarbrick; David V Doyle; Alan J Schafer; Tim D Spector Journal: Arthritis Rheum Date: 2004-08
Authors: Barbora Vesela; Martina Zapletalova; Eva Svandova; Alice Ramesova; Jaroslav Doubek; Hervé Lesot; Eva Matalova Journal: Cartilage Date: 2021-09-08 Impact factor: 3.117
Authors: Jakob T Sieker; Benedikt L Proffen; Kimberly A Waller; Kaitlyn E Chin; Naga Padmini Karamchedu; Matthew R Akelman; Gabriel S Perrone; Ata M Kiapour; Johannes Konrad; Martha M Murray; Braden C Fleming Journal: J Orthop Res Date: 2017-08-03 Impact factor: 3.494
Authors: A He; Y Ning; Y Wen; Y Cai; K Xu; Y Cai; J Han; L Liu; Y Du; X Liang; P Li; Q Fan; J Hao; X Wang; X Guo; T Ma; F Zhang Journal: Bone Joint Res Date: 2018-06-05 Impact factor: 5.853
Authors: Purva Singh; Samantha G Lessard; Piali Mukherjee; Brennan Rourke; Miguel Otero Journal: Ann N Y Acad Sci Date: 2020-09-25 Impact factor: 5.691
Authors: Kwang Il Lee; Ramya Gamini; Merissa Olmer; Yasunari Ikuta; Joe Hasei; Jihye Baek; Oscar Alvarez-Garcia; Shawn P Grogan; Darryl D D'Lima; Hiroshi Asahara; Andrew I Su; Martin K Lotz Journal: Sci Transl Med Date: 2020-10-28 Impact factor: 19.319
Authors: Sarah J Rice; Guillaume Aubourg; Antony K Sorial; David Almarza; Maria Tselepi; David J Deehan; Louise N Reynard; John Loughlin Journal: Hum Mol Genet Date: 2018-10-01 Impact factor: 6.150